IMPROVEMENT OF PRICE REGULATION FOR INNOVATIVE MEDICINES COVERED BY THE NATIONAL BUDGET
The current approaches to the drug pricing commonly used worldwide allow for incorporating the therapeutic value of the drug into its consumer price. The drug pricing system existing in the Russian Federation restricts the availability of highly effective innovative drugs and leads to unnecessary ex...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Russo |
| Julkaistu: |
IRBIS LLC
2018-02-01
|
| Sarja: | Фармакоэкономика |
| Aiheet: | |
| Linkit: | https://www.pharmacoeconomics.ru/jour/article/view/215 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|